Latest / Understanding the Brain / How the Brain Adapts to Antidepressants: Receptors, Circuits, and Neuroplasticity

Transcript

How the Brain Adapts to Antidepressants: Receptors, Circuits, and Neuroplasticity · Understanding the Brain

• 0:01
  Speaker 1: Well, I'll try to answer one of the most popular
• 0:04
  Speaker 1: questions in the world of psychopharmacology. Why do antidepressants sometimes
• 0:09
  Speaker 1: stop working? So you have a patient who's taken an
• 0:12
  Speaker 1: antidepressant for three years. During the first several months, the
• 0:15
  Speaker 1: medication appears to be working effectively. Their mood improves, concentration returned,
• 0:20
  Speaker 1: sleep is better. Then gradually something changes. The familiar symptoms
• 0:23
  Speaker 1: begin returning. The patient was taking the same medication at
• 0:26
  Speaker 1: the same dose, yet the benefits seem to be disappearing.
• 0:30
  Speaker 1: Have the brain developed a tolerance to the antidepressant? This
• 0:33
  Speaker 1: phenomenon is sometimes called antidepressant tachyphylaxis. Although the term is
• 0:39
  Speaker 1: often used loosely to describe an apparent loss of a
• 0:42
  Speaker 1: previously successful treatment response, the first challenge is determining whether
• 0:46
  Speaker 1: the medication has truly stopped working. Depression is frequently recurrent.
• 0:50
  Speaker 1: A person may experience a new depressive episode despite continuing
• 0:53
  Speaker 1: a medication that previously helped. Other factors can also produce
• 0:57
  Speaker 1: the appearance of medication failure. These include missile doses, changes
• 1:02
  Speaker 1: in sleep, significant stress, substance abuse, substance use, medications. For
• 1:07
  Speaker 1: some patients, an emerging bipolar disorder or another psychiatric condition
• 1:11
  Speaker 1: may also complicate the clinical picture. Before assuming that the
• 1:15
  Speaker 1: brain has become tolerant to medication, clinicians must consider these possibilities.
• 1:19
  Speaker 1: What about actual neurobiological adaptations? Many antidepressants influence monamine neurotransmission,
• 1:25
  Speaker 1: particularly serotonin and epinephrine. SSRIs reduce serotonin reuptake, increasing serotonin
• 1:31
  Speaker 1: availability in the synaptic air environment. However, antidepressant effects cannot
• 1:37
  Speaker 1: be explained simply by increasing neurotransmitter. Over time, treatment is
• 1:42
  Speaker 1: associated with changes in receptor signaling, neural circuitry, and processes
• 1:46
  Speaker 1: related to neuroplasticity. Researchers have proposed that longer-term adaptations in
• 1:52
  Speaker 1: these systems might contribute to diminished response in some individuals. Nevertheless,
• 1:57
  Speaker 1: the precise mechanisms of antidepressant tachyphylaxis remain uncertain. It would
• 2:02
  Speaker 1: be misleading to suggest that serotonin receptors simply become exhausted
• 2:05
  Speaker 1: or that the brain inevitably becomes immune to antidepressants. Another
• 2:10
  Speaker 1: important consideration is pharmacokinetics. A medication's effectiveness depends partly on
• 2:15
  Speaker 1: how the body reacts absorbs, distributes, metabolizes, or eliminates it.
• 2:21
  Speaker 1: Changes in other direct medications, health conditions, or metabolic processes
• 2:25
  Speaker 1: can alter drug exposure. Even when the prescribed dosage remains unchanged,
• 2:31
  Speaker 1: the effective concentration of medication may differ. Psychological and environmental
• 2:36
  Speaker 1: factors also matter. It may mean that the overall burden
• 2:43
  Speaker 1: of depression has changed, so what happens when antidepressant benefits
• 2:46
  Speaker 1: appear to diminish? Clinicians generally begin by reassessing the diagnosis, adherence,
• 2:51
  Speaker 1: and symptom pattern. Depending on the circumstances, treatment options may
• 2:54
  Speaker 1: include adjusting of the dosage, switching antidepressants, and adding an
• 2:57
  Speaker 1: evidence-based strategy. The appropriate approach depends on the individual, the medication,
• 3:03
  Speaker 1: and the clinical assessment. When an antidepressant seems to stop working,
• 3:10
  Speaker 1: the most important question is not merely whether the medication
• 3:13
  Speaker 1: has lost its power. It is what has changed in
• 3:16
  Speaker 1: the patient, the illness, or the surrounding circumstances. That's the
• 3:21
  Speaker 1: important question to remember.